Skip to main content

Introduction to Statistics and Modeling Methods Applied in Health Economics

  • Chapter
  • First Online:
Mental Health Economics

Abstract

The increasing complexity of health economics methodology has raised the need for technical methods to systematically use patient-level data and characterize uncertainty around the decision problem for decision makers. This chapter provides an introduction to these methods, focusing on trial-based statistical techniques and economic modeling methods for the purpose of health economic analysis. This chapter describes some differences between the more commonly used frequentist approach for clinical analysis and the developing use of Bayesian methods for health economic analysis. Statistical methods described include the use of power calculations, hypothesis testing, and regression analysis, and their relevance for economic analysis. More advanced statistical methods are also introduced, such as the area under the curve method for assessing incremental benefit, controlling for missing data and baseline characteristics, and using mapping algorithms for eliciting preference-based tariff scores when a preference-based measure has not been collected within a study. The second part of the chapter focuses on modeling methods designed to synthesize data from multiple sources when the economic analysis needs to go beyond a single source of primary data or for a longer time horizon. Multiple types of economic models are described, including decision trees, state transition models (including Markov chain models), microsimulation, and discrete event simulation. The chapter breaks down key elements of model design and offers recommendations on possible sources of data that may be used to derive parameter estimates. The conclusion of the chapter includes recommendations for appropriately reporting results of the statistical and modeling analyses carried out as part of an economic evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jones AM, Rice N, d’Uva TB, Balia S. Applied health economics. Abingdon: Routledge; 2013.

    Google Scholar 

  2. Ades A, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Mak. 2004;24(2):207–27.

    Article  CAS  Google Scholar 

  3. Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ. 2007;16(2):195–209.

    Article  PubMed  Google Scholar 

  4. Al-Janabi H, Peters TJ, Brazier J, Bryan S, Flynn TN, Clemens S, et al. An investigation of the construct validity of the ICECAP-A capability measure. Qual Life Res. 2013;22(7):1831–40.

    Article  PubMed  Google Scholar 

  5. Coast J, Peters TJ, Natarajan L, Sproston K, Flynn T. An assessment of the construct validity of the descriptive system for the ICECAP capability measure for older people. Qual Life Res. 2008;17(7):967–76.

    Article  PubMed  Google Scholar 

  6. Malley JN, Towers A-M, Netten AP, Brazier JE, Forder JE, Flynn T. An assessment of the construct validity of the ASCOT measure of social care-related quality of life with older people. Health Qual Life Outcomes. 2012;10(1):1.

    Article  Google Scholar 

  7. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197–204.

    Article  Google Scholar 

  8. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation?: comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23(3):525–42.

    Article  PubMed  Google Scholar 

  9. Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13(3):381–9.

    Article  Google Scholar 

  10. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Kotz, Samuel, Johnson, Norman L, editors. Breakthroughs in statistics. New York: Springer; 1992. p. 610–24.

    Google Scholar 

  11. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461–4.

    Article  Google Scholar 

  12. Ramsey JB. Tests for specification errors in classical linear least-squares regression analysis. J R Stat Soc Ser B Methodol. 1969:350–71.

    Google Scholar 

  13. Park RE. Estimation with heteroscedastic error terms. Econometrica. 1966;34(4):888.

    Article  Google Scholar 

  14. Jarque CM, Bera AK. A test for normality of observations and regression residuals. Int Stat Rev/Revue Internationale de Statistique. 1987;55:163–72.

    Google Scholar 

  15. Bozdogan H. Model selection and Akaike’s information criterion (AIC): the general theory and its analytical extensions. Psychometrika. 1987;52(3):345–70.

    Article  Google Scholar 

  16. Burnham KP, Anderson DR. Multimodel inference understanding AIC and BIC in model selection. Sociol Methods Res. 2004;33(2):261–304.

    Article  Google Scholar 

  17. Ciarrochi J, Deane FP, Anderson S. Emotional intelligence moderates the relationship between stress and mental health. Personal Individ Differ. 2002;32(2):197–209.

    Article  Google Scholar 

  18. Meltzer H, Bebbington P, Brugha T, Farrell M, Jenkins R. The relationship between personal debt and specific common mental disorders. Eur J Public Health. 2013;23(1):108–13.

    Article  PubMed  Google Scholar 

  19. Miller CJ, Grogan-Kaylor A, Perron BE, Kilbourne AM, Woltmann E, Bauer MS. Collaborative chronic care models for mental health conditions: cumulative meta-analysis and meta-regression to guide future research and implementation. Med Care. 2013;51(10):922.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34).

    Google Scholar 

  21. Lepage R, Billard L. Exploring the limits of bootstrap. New York: John Wiley & Sons; 1992.

    Google Scholar 

  22. Efron B. The jackknife, the bootstrap and other resampling plans: society for industrial and applied mathematics (SIAM). Philadelphia: Society for Industrial and Applied Mathematics; 1982.

    Book  Google Scholar 

  23. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171–85.

    Article  Google Scholar 

  24. Efron B. Bayesian inference and the parametric bootstrap. Ann Appl Stat. 2012;6(4):1971.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Efron B, Tibshirani RJ. An introduction to the bootstrap. Boca Raton: CRC Press; 1994.

    Google Scholar 

  26. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327–40.

    Article  CAS  PubMed  Google Scholar 

  27. Gomes M, Grieve R, Nixon R, Edmunds W. Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials a systematic review and checklist for critical appraisal. Med Decis Mak. 2012;32(1):209–20.

    Article  Google Scholar 

  28. O’Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ. 2003;12(1):33–49.

    Article  PubMed  Google Scholar 

  29. Hunter RM, Baio G, Butt T, Morris S, Round J, Freemantle N. An educational review of the statistical issues in analysing utility data for cost-utility analysis. PharmacoEconomics. 2015;33(4):355–66.

    Article  PubMed  Google Scholar 

  30. Committee for Medicinal Products for Human Use (CHMP) Guideline on adjustment for baseline covariates. European Medicines Agency. 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/06/WC500144946.pdf. Accessed 4 Oct 2016.

    Google Scholar 

  31. van Asselt AD, van Mastrigt GA, Dirksen CD, Arntz A, Severens JL, Kessels AG. How to deal with cost differences at baseline. PharmacoEconomics. 2009;27(6):519–28.

    Article  Google Scholar 

  32. Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley; 2002.

    Book  Google Scholar 

  33. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27(1):85–96.

    Google Scholar 

  34. Landerman LR, Land KC, Pieper CF. An empirical evaluation of the predictive mean matching method for imputing missing values. Sociol Methods Res. 1997;26(1):3–33.

    Article  Google Scholar 

  35. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.

    Article  PubMed  Google Scholar 

  36. Longworth L, Rowen D. NICE DSU technical support document 10: the use of mapping methods to estimate health state utility values. Sheffield: Decision Support Unit, ScHARR, University of Sheffield; 2011. p. b4.

    Google Scholar 

  37. Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes. 2013;11(1):1.

    Article  Google Scholar 

  38. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet. 2002;360(9334):711–5.

    Article  PubMed  Google Scholar 

  39. Stevenson MD, Scope A, Sutcliffe PA, Booth A, Slade P, Parry G, et al. Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses. Health Technol Assess. 2010;14(44):1–107. iii–iv

    Article  CAS  Google Scholar 

  40. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Med Decis Mak. 2012;32(5):690–700.

    Article  Google Scholar 

  41. Briggs A, Campbell H, Clarke P. Parametric survival models and decision models: relating continuous hazards to discrete-time transition probabilities. Glasgow: Health Economists’ Study Group; 2004.

    Google Scholar 

  42. Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Moller J. Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4. Med Decis Mak. 2012;32(5):701–11.

    Article  Google Scholar 

  43. Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess. 2005;9(16):1–134. iii

    Article  CAS  Google Scholar 

  44. Centre for Reviews and Dissemination. Available from: http://www.crd.york.ac.uk/CRDWeb/. Accessed 6 Oct 2016.

  45. School of Health and Related Research. Health utility database. Available from: http://www.scharrhud.org/. Accessed 06 Oct 2016.

  46. Bangor University. Database of instruments for resource use measurement. Available from: http://www.dirum.org/. Accessed 06 Oct 2016.

  47. Department of Health. NHS reference costs 2014 to 2015. Available from: https://www.gov.uk/government/publications/nhs-reference-costs-2014-to-2015. Accessed 16 Feb 2016.

  48. Personal Social Services Research Unit. Unit costs of health and social care 2015. Available from: http://www.pssru.ac.uk/project-pages/unit-costs/2015/index.php. Accessed 16 Feb 2016.

  49. British National Formulary. BNF 70. London: British Medical Association & The Royal Pharmaceutical Society; 2015.

    Google Scholar 

  50. Claxton K. Exploring uncertainty in cost-effectiveness analysis. PharmacoEconomics. 2008;26(9):781–98.

    Article  PubMed  Google Scholar 

  51. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6. Med Decis Mak. 2012;32(5):722–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vladislav Berdunov .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Berdunov, V., Franklin, M. (2017). Introduction to Statistics and Modeling Methods Applied in Health Economics. In: Razzouk, D. (eds) Mental Health Economics. Springer, Cham. https://doi.org/10.1007/978-3-319-55266-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55266-8_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55265-1

  • Online ISBN: 978-3-319-55266-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics